Plasma Follicle-stimulating Hormone Concentrations Research Articles

顆粒膜細胞腫に罹患した黒毛和種牛2例の内分泌学的検索

Certain endocrinological characteristics of granulosa cell tumors (GCT) in two Japanese Black cows were described. The ages and parity of the two cows were 12 years old and 9, and 4 years old and 2. Plasma samples were taken from the jugular vein from 213 to 170 days prior to the surgical removal of the affected ovaries with GCT and from nine days prior to the removal to ten days after the removal in Case A, and from 85 days prior to two days after the removal of the affected ovary in Case B. Plasma concentrations of estradio1-17β, progesterone, testosterone, inhibin and follicle-stimulating hormone (FSH) were measured by radioimmunoassay. The two cases showed no distinct estrous sign or abnormal estrous behavior. Plasma concentrations of inhibin remained high before the ovarian removal, and declined abruptly after the removal in the two cases. In contrast, plasma concentrations of FSH increased after surgery. In conclusion, it is suggested that inhibin secreted from the ovary of a cow with GCT may be biologically active, and that the elevation of plasma concentration of inhibin could be a useful indicator for the diagnosis of bovine GCT.

Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17β, progesterone, prolactin, and α-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch

Compared with other domestic animals, relatively little is known about the changes in, and temporal relations between, reproductive hormones around the time of ovulation in the domestic bitch. Therefore, plasma concentrations of luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol-17β, progesterone, prolactin (PRL), and α-melanocyte-stimulating hormone (α-MSH) were determined one to six times daily from the start of the follicular phase until 5 days after the estimated day of ovulation in six Beagle bitches. In all bitches, the pre-ovulatory LH surge was accompanied by a pre-ovulatory FSH surge. A pre-ovulatory PRL or α-MSH surge was not observed. The pre-ovulatory FSH and LH surges started concomitantly in four bitches, but in two bitches the FSH surge started 12 h earlier than the LH surge. The FSH surge (110 ± 8 h) lasted significantly longer than the LH surge (36 ± 5 h). In contrast with the pre-ovulatory FSH surge, the pre-ovulatory LH surge was bifurcated in four of six bitches. The mean plasma LH concentrations before (1.9 ± 0.4 μg/L) and after (1.9 ± 0.3 μg/L) the LH surge were similar, but the mean plasma FSH concentration before the FSH surge (1.6 ± 0.3 U/L) was significantly lower than that after the FSH surge (3.1 ± 0.2 U/L). In most bitches the highest plasma estradiol-17β concentration coincided with or followed the start of the pre-ovulatory LH surge. In five of the six bitches the plasma progesterone concentration started to rise just before or concurrently with the start of the LH surge. In conclusion, the results of this study provide evidence for the differential regulation of the secretion of LH and FSH in the bitch. In addition, the interrelationship of the plasma profiles of estradiol-17β and LH suggests a positive feedback effect of estradiol-17β on LH surge release. The start of the pre-ovulatory LH surge is associated with an increase in the plasma progesterone concentration in this species.

The Stimulatory Role of Estrogen on Sperm Motility in the Male Golden Hamster (Mesocricetus auratus)

To clarify the physiological roles of estrogens in the regulation of sperm motility in the golden hamster, two different approaches were used. In the first experiment, silastic tubes containing either low (low E2 group) or high (high E2 group) amount of estradiol-17beta were implanted (Exp 1). In the second experiment, male golden hamsters were actively immunized against estradiol-17beta (Exp 2). In Exp 1, all sperm motility parameters (including motility, straight velocity, curvilinear velocity, beat/cross frequency, and mean amplitude of lateral head displacement) were significantly increased except linear index in the high E2 group as compared with controls at 20 days after the treatment. In the high E2 group, plasma concentrations of luteinizing hormone (LH) significantly increased, whereas levels of circulating testosterone decreased significantly. Plasma concentrations of follicle-stimulating hormone (FSH) and immunoreactive inhibin were not affected by the treatment with estradiol-17beta. In the Exp 2, titer of circulating antibodies to estradiol-17beta consistently increased after the second immunization until the end of experiment (16 weeks). The sperm motility, straight velocity, and curvilinear velocity were significantly decreased after active immunization to estradiol-17beta. Concentrations of circulating LH and FSH were also decreased significantly by the treatment. In conclusion, the current observations indicate that estradiol-17beta affects sperm motility in adult male golden hamsters.

Lighting regimens and plasma LH and FSH in broiler breeders

1. Egg production by meat-type fowl is markedly inferior to that from commercial laying hens, and so, to assess the degree to which photorefractoriness might be a contributing factor, male- and female-line broiler breeders were maintained on 8-, 11- or 16-h photoperiods. In addition, to determine the age-related rate of change in response to an increment in photoperiod, other birds were transferred from 8- to 16-h photoperiods at 67 or 124 d. 2. Blood samples were taken from all groups, except those on constant 11-h photoperiods, in both genotypes at 67, 69, 124 and 126 d, and from all lighting groups in the female line at 58 weeks (end of trial), and the plasma was assayed for plasma luteinising hormone (LH) and follicle stimulating hormone (FSH) concentration to investigate possible correlations with rate of sexual maturity, total egg numbers and terminal rates of lay. 3. Prepubertal LH was consistently higher for the female line than for the male line, and higher for 16-h birds than for 8-h birds. At 69 and 126 d, LH values were not significantly different from those 2 d earlier for 8-h birds, but significantly reduced for 16-h birds. There was an increase in LH following photostimulation at 67 d, but no significant change after the 124-d light increase. 4. There were no significant differences in FSH between the two genetic lines, nor any effect of photostimulation at 67 or 124 d. There was a tendency for FSH in 8-h birds to be higher than for 16-h birds, and this difference became significant for male-line birds at 67 d. 5. At 58 weeks, LH was higher for constant 11- and 16-h birds and for birds photostimulated at 67 d than for constant 8-h controls or birds transferred from 8 to 16 h at 124 d. 6. Neither baseline nor photoinduced prepubertal changes in plasma LH nor FSH were found to be of value for predicting age at sexual maturity or subsequent rates of egg production. At 58 weeks, LH was not generally correlated with sexual maturity, total eggs or terminal rates of lay, however, there was a negative correlation with age at first egg in birds photostimulated at 124 d. 7. It must be concluded that plasma LH and FSH concentrations are of minimal value to the broiler breeder industry for predicting the degree of photorefractoriness, the age at sexual maturity, or subsequent egg production.

Correlations Between Seminal Plasma Hormones and Sperm Biophysical Parameters in Infertile Males in Ibadan

Context: There is a complex relationship between seminal plasma hormone levels and infertility in men. Previous studies had shown no specific pattern in the serum or seminal plasma hormone profiles of men with infertility and it is debatable whether there is a need to perform routine seminal hormone assays in the management of men with infertility. Objective: The aim of this study is to determine of there is a relationship between seminal plasma hormone levels and semen biophysical parameters in infertile males. Study Design, Setting and Subjects: Healthy male volunteers, comprising 20 normozoospermics, 20 oligozoospermics and 11 azoospermics were recruited from the Urology and Gynaecology Clinics at the University College Hospital, Ibadan. Semen samples were analysed according to the WHO guidelines and seminal plasma prolactin, follicle-stimulating hormone (FSH), luteinising hormone (LH) and testosterone concentrations were estimated by enzyme immunometric method according to the WHO protocol. Main Outcome Measures: The correlation between semen biophysical parameters and seminal plasma hormone levels in infertile men. Results: A significant positive correlation was seen between seminal plasma FSH concentration and seminal plasma volume in all subjects. In normozoospermic men, significant correlation was found only between prolactin concentration and sperm viability and between LH concentration and sperm motility. However, in oligozoospermic males, prolactin concentration had significant positive correlation with sperm count and motility while LH concentration had significant positive correlation with sperm motility only. Conclusion:Seminal plasma hormone assays are of no value in assessing male infertility. Key Words: Semen, Seminal Plasma, Gonadotropins, Infertility. [Trop J Obstet Gynaecol, 2003, 20: 7-11]

Lack of an association between plasma follicle-stimulating hormone concentrations and ovarian weight in prepubertal gilts1

Lack of an association between plasma follicle-stimulating hormone concentrations and ovarian weight in prepubertal gilts1

Lack of an association between plasma follicle-stimulating hormone concentrations and ovarian weight in prepubertal gilts.

Selection for increased number of corpora lutea in gilts is associated with increased plasma FSH concentrations during pubertal development. In the current study, 270 gilts from a control (CO) line and a line selected for increased ovulation rate (OR) were unilaterally ovariectomized at 85 d of age, and this ovarian weight was related to FSH concentrations at 65, 75, and 85 d of age. Gilts were produced during two farrowing seasons, spring and fall, and the age at first estrus was monitored from 160 to 250 d. Plasma FSH was greater in OR than in CO gilts at 65 (P < 0.01) and 75 d (difference in spring greater than in fall, P < 0.01), but FSH at these ages was not correlated with ovarian weight at 85 d. At 85 d, FSH did not differ in gilts of these lines; however, FSH was negatively correlated (r = -0.27, P < 0.01) with ovarian weight. The proportion of gilts detected in estrus was less for spring-born CO gilts than for spring-born OR or for fall-born CO and OR gilts (78 vs. 92%, season x line, P < 0.02). The age at first estrus was similar in the two lines but was earlier (P < 0.01) for spring-born than for fall-born gilts (194 vs. 204 d). Concentrations of FSH at each of the ages examined were not correlated with the age at first estrus. These observations support the conclusion that selection for a greater number of corpora lutea produces a correlated increase in plasma FSH during early pubertal development. This increase in FSH most likely reflects differences in FSH synthesis and release and not differences in the stage of pubertal development.

Postpartum gonadotropin secretion in Holstein-Friesian dairy cows differing genetically in liveweight

AIM: To determine whether there are differences in postpartum gonadotrophic activity between strains of Holstein-Friesian dairy cows genetically selected on mature liveweight that might explain differences between the strains in fertility, and the interval between calving and the resumption of ovarian follicular activity. METHODS: Mixed-age Holstein-Friesian cows fed generous allowances of ryegrass/white clover pasture, and genetically selected for heavy (H) or light (L) mature liveweight, were given 10 µg buserelin on Days 21, 28, 35 and 42 (Experiment 1a;n=8/ group), or Days 7, 14, 21 and 28 (Experiment 1b; n=8/group) postpartum. The same dose of buserelin was also given to first-calved heifers from each strain (Experiment 1c; n=6/group) on Days 7, 14, 21, and 28 postpartum. Luteinising hormone (LH) concentrations were measured in serial blood samples that were taken for up to 240 min after administration of buserelin. In Experiment 2, serial blood samples were taken at 15-min intervals from H and L cows (n=7/group) over 8 h on Days 14, 21, 28 and 35 postpartum, to examine the endogenous secretion patterns of LH and follicle stimulating hormone (FSH). The time-course of the restoration of positive feedback between oestradiol and LH was examined by giving 1 mg oestradiol ben-zoate (ODB) 48 h after administration of 500 µg cloprostenol to mixed-age cows from each strain on Days 7 and 21 (n=8/group), or 14 and 28 (n=8/group) after calving (Experiment 3). Relationships between nutrition and the restoration of positive feedback were studied by giving 0.75 mg ODB/500 kg liveweight on Day 17 or 18 after calving to pure-bred Holstein (OSH) and New Zealand Friesian (NZF) cows that were fed either pasture (n= 12 OSH, 12 NZF) or a total mixed ration (TMR; n= 13 OSH, 12 NZF) (Experiment 4). Plasma LH and FSH concentrations were measured in samples collected for 42 h (Experiment 3) or 48 h (Experiment 4) after treatment with ODB. Milk progesterone concentrations were measured 3x weekly to define the reproductive status of animals in each experiment. Conception rates were recorded for animals in all of the experiments. RESULTS: First-service conception rates were lower (p<0.05) in H than L cows (46% vs 59%). In Experiments 1b and 1c, LH response to buserelin increased between Days 7 and 28 postpar-tum (both p<0.001), but did not differ between strains (p=0.77 and p=0.19, respectively). In Experiment 1a, LH responses to buserelin did not change between Days 21 and 42 postpar- tum, but overall mean peak concentrations were significantly (p<0.001) greater in L than H cows. In Experiment 2, anoestrous H cows had higher mean (p=0.004) and episodic (p=0.001) concentrations of LH than did L cows, but in cows that had active corpora lutea there were no such differences. There were no differences in FSH concentrations between strains. LH secretion in response to exogenous oestradiol (Experiment 3) increased between Days 7 and 28 postpartum (p<0.001), but there were no differences between strains. Responses were also similar in OSH and NZF cows on Day 17 or 18 postpartum, although there was a significant effect of ration upon the proportion of cows that exhibited an LH surge (20/24 cows on grass vs 12/25 on a TMR; p=0.005). CONCLUSION: These results confirm that H cows have poorer first-service conception rates than L cows, but do not support an hypothesis that there are major differences between these strains of Holstein-Friesian dairy cows in the rate of restoration in the hypothalamo-pituitary axis. However, in anoestrous cows, differences between strains in the endogenous release of LH may be related to an earlier onset of oestrous cycles in H animals.

Endocrinological changes before and after removal of the granulosa theca cell tumor (GTCT) affected ovary in 6 mares.

To clarify the endocrinological characteristics of the mares with granulosa theca cell tumor (GTCT), peripheral plasma samples from the 6 mares affected with GTCT were collected before and after the surgical removal of the affected ovary. Concentrations of testosterone (T), follicle stimulating hormone (FSH), luteinizing hormone (LH), immunoreactive-inhibin (ir-INH), progesterone (P) and estradiol-17beta (E(2)) in the plasma samples were measured by radioimmunoassay. Before removal of GTCT in all cases, the concentrations of T were significantly higher than those of normal mares at the breeding and non-breeding seasons, whereas plasma concentrations of FSH, LH, ir-INH, P and E(2) were lower. After surgical removal of the affected ovary, the circulatory concentrations of T was declined, but the concentrations of other hormones were constantly low as compared with those of normal mares. The present study suggests that 1) the source of higher T may be due to the abnormal follicles in ovary of GTCT, 2) in the case of GTCT the elevated level of T is observed due to the lack of aromatase, and 3) the high level of T is a typical characteristics for GTCT in mares. It is also suggested 4) due to the elevated levels of T the concentrations of gonadotropins may be suppressed.

Changes in expression of inhibin subunits in the cyclic golden hamster (Mesocricetus auratus) and the regulation of inhibin alpha subunit production by luteinizing hormone.

In the present study, changes in localization of each inhibin subunit in the ovary were investigated during the estrous cycle of the golden hamster. The effect of LH surge on changes in localization in inhibin alpha subunit in the ovary was also investigated. Inhibin alpha subunit was localized in granulosa cells of various stages of follicles throughout the estrous cycle. Inhibin alpha subunit was also present in numerous interstitial cells on days 1 and 2 (day 1 = day of ovulation), but the number of positive interstitial cells was fewer on days 3 and almost disappeared on day 4 of the estrous cycle. Newly formed luteal cells were also positive for inhibin alpha subunit on days 1 and 2. On the other hand, positive reactions for inhibin beta A and beta B subunits were only present in the granulosa cells of healthy antral follicles. However, a positive reaction for inhibin beta B subunit in peripheral mural granulosa cells disappeared on days 3 and 4 of the estrous cycle. Treatment with LHRH-AS at 1100 h on day 4 completely blocked the luteinizing hormone (LH) surge and ovulation, although relatively high concentrations of plasma follicle-stimulating hormone (FSH) were maintained throughout the experiment. There were few positive reactions for inhibin alpha subunit in theca and interstitial cells 24 hr after LHRH-AS injection. The effect of LHRH-AS treatment was blocked by a single injection of 10 IU human chorionic gonadotropin. These results suggest that the major source of dimeric inhibin in the cyclic hamster was granulosa cells of healthy antral follicles. Different distribution pattern of inhibin beta A from beta B subunits in large antral follicles on days 3 and 4 of the estrous cycle suggests different secretion patterns of inhibin A from B on these days. Furthermore, the LH surge may be an important factor to induce production of inhibin alpha subunit in interstitial cells of the cyclic hamster.

Low maternal nutrition during pregnancy reduces the number of Sertoli cells in the newborn lamb

The nutritional status of females during pregnancy can play a critical role in the postnatal growth and development of the offspring, often leading to permanent changes ('fetal programming'). The Sertoli cells are a strong candidate for fetal programming of future performance because the number of Sertoli cells is highly correlated with adult testicular size and the maximum rate of sperm production. For Merino ewes, we imposed different levels of metabolizable energy (ME) intake (LowME: 70% of requirements for maintenance of ewe body mass and normal growth of conceptus (n = 13); HighME: 110% of those requirements (n = 12)) from Week 10 of pregnancy until parturition and then tested for effects on testicular histology in newborn males. Pregnant ewes were weighed weekly and lambs were weighed at birth and 2 days later. Blood was sampled at the same times. LowME ewes did not gain weight, whereas HighME ewes gained 17% over their pretreatment weight. Birthweights were higher in HighME lambs than in LowME lambs. Paired testes tended to be heavier in the HighME group than in the LowME group (P=0.08). The diameter of the testicular cords did not differ. The absolute volume of testicular cords (0.36 +/- 0.02 v. 0.30 +/- 0.02 mL for HighME v. LowME, respectively; P=0.03) and the number of Sertoli cells (43.0 +/- 2.5 v. 34.5 +/- 2.0 x 10(8) for HighME v. LowME, respectively; P=0.018) per testis were both greater in the HighME than in the LowME group. Plasma follicle-stimulating hormone concentrations were not significantly affected at birth or 2 days later. We conclude that undernutrition during pregnancy can reduce testicular development in the newborn. Depending on the ability of the Sertoli cell population to recover between birth and puberty, this may limit the ultimate number of Sertoli cells and, hence, the future capacity for sperm production and fertility.

Elevated levels of inhibin-A and immunoreactive inhibin in aged male Wistar rats with testicular Leydig cell tumor.

This study was undertaken to investigate the endocrine changes that occur in male Tig:Wistar rats with Leydig cell tumors, with special reference to immunoreactive inhibin (ir-inhibin) and its dimeric forms. Adult male rats from 2 to 28 months of age were used. Blood samples were taken to measure plasma concentrations of ir-inhibin, inhibin-A, inhibin-B, 17beta-estradiol (E2), testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH). Inhibin bioactivity in both peripheral plasma and testicular extracts was also measured. Rats aged 18 months and older had testicular Leydig cell tumor. Testicular tissue sections from 27-month-old rats examined immunohistochemically showed strong positive staining for all 3 inhibin subunits, in particular inhibin alpha and betaA subunits, in the tumor cells. Plasma concentrations of ir-inhibin began to rise significantly (P < .05) at 18 months of age. High bioactivity of inhibin was detected not only in testicular extracts but also in peripheral plasma of aged rats. Thus, plasma concentrations of bioactive inhibin-A, but not inhibin-B, were significantly elevated with increasing age. The concentrations were significantly higher than those in normal male (P < .01) or normal female (P < .05) rats. Plasma concentrations of E2 were significantly (P < .05) elevated only at 23-24 months of age. A marked reduction (P < .05 to .001) in plasma LH and FSH concentrations was observed at 18 months of age and older. Plasma concentrations of testosterone were highest at 2 months of age and then decreased gradually and significantly (P < .05 to .001) afterward. Significant (P < .05 to .001) positive (testosterone vs LH) and negative (ir-inhibin vs FSH, ir-inhibin vs LH, and E2 vs FSH) correlations were observed. It is suggested that plasma inhibin-A levels are elevated in male Tig:Wistar rats with Leydig cell tumor, and thus inhibin-A may be used as a specific marker of testicular Leydig cell tumors. The present results also suggest that the age-related decline in plasma gonadotropins and thus testosterone levels in Tig:Wistar rats may be due to the development of tumors of the Leydig cells rather than to aging per se.

Identification of genomic regions controlling plasma FSH concentrations in Meishan-White Composite boars.

The Chinese Meishan (ME) breed of pig is unique for many reproductive traits. Compared with Western breeds of swine, ME females reach puberty earlier, ovulate more ova per estrus, and have greater uterine capacity, while intact males (boars) have smaller testes and extremely elevated plasma levels of pituitary-derived glycoprotein hormones. In an effort to identify the genetic mechanisms controlling the elevated plasma levels of pituitary-derived glycoprotein hormones [in particular, follicle-stimulating hormone (FSH)] and to determine whether some of these genetic factors are also responsible for differences in other phenotypes, we scanned the entire genome for regions that affected plasma FSH in boars from a Meishan-White Composite (equal contributions of Chester White, Landrace, Large White, and Yorkshire) resource population. Initially, the entire genome of 121 boars was scanned for regions that potentially influenced plasma FSH. The most significant genomic regions were further studied in a total of 436 boars. Three genomic regions located on chromosomes 3, 10, and X apparently possess genes that significantly affect FSH level, and one region provided suggestive evidence for the presence of FSH-controlling genes located on chromosome 8. The region on the X chromosome also affected testes size. Similar genomic regions to those identified on chromosomes 3, 8, and 10 in this study have been identified to affect ovulation rate in female litter mates, supporting the hypothesis that plasma FSH in pubertal boars and ovulation rate in females is controlled by a similar set of genes.

Estrogen replacement therapy in postmenopausal women: a study of the efficacy of estriol and changes in plasma gonadotropin levels

The purpose of this study was to clarify the efficacy of estriol for estrogen replacement therapy in postmenopausal women with undefined symptoms and to evaluate endocrinological changes during therapy in relation to clinical outcome. Administration of 2 mg estriol in 168 postmenopausal patients was markedly effective in 22.6% of cases, effective in 45.2%, fairly effective in 14.3%, and ineffective in 17.9% of cases. The plasma concentration of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) after administration of estriol decreased significantly (p < 0.001), by 52.2% and 32.9%, respectively for markedly effective cases, and by 39.1% and 48.0% for effective cases. In contrast, the plasma estradiol concentration remained unchanged. On the other hand, decreases in FSH and LH concentration were 13.9% and 5.9% for the fairly effective and 8.2% and 1.9% for ineffective cases, demonstrating a significantly lower decrease in plasma FSH and LH levels than in the markedly effective and effective cases (p < 0.001). For cases showing side-effects, the plasma FSH and LH levels decreased by 52.0% and 64.3%, respectively, whereas the plasma estradiol level remained unchanged. In conclusion, the efficacy of estriol was significantly correlated to the degree of decrease in plasma FSH and LH levels in patients with undefined symptoms. In addition, efficacy appeared to be correlated to the incidence of side-effects. The degree of reduction of FSH (39.1-52.2%) and LH (48.0-64.3%) from the baseline may possibly be used as a guide to the therapeutic hormone levels during HRT. The present results suggest that plasma gonadotropin levels could be a useful indicator in the management of patients undergoing estrogen replacement therapy.

Contribution of endogenous inhibin to the decline of the secondary surge of follicle-stimulating hormone in the rat.

The involvement of inhibin in the decline of the secondary surge of follicle-stimulating hormone (FSH) was investigated in the rat. After ovariectomy or treatment with inhibin antiserum conducted at 2300 hours during pro-oestrus, plasma concentrations of FSH were maintained at high levels compared with control rats. However, plasma FSH started to decline at 0500 hours during oestrus in both the groups. The same treatments conducted during metoestrus markedly increased plasma FSH after 24 h (twofold compared with the treatments during pro-oestrus), suggesting that the treatments sufficiently depleted circulating inhibin. To examine whether the decline of plasma FSH occurred through a transcriptional mechanism or through a translational mechanism, FSH-beta mRNA expression and the pituitary concentration of FSH were measured. Neither ovariectomy nor inhibin immunization conducted during the night of pro-oestrus, affected the pituitary concentration of FSH after 24 h, whereas a noticeable increase was observed after the treatments conducted during metoestrus. In both stages, both ovariectomy and inhibin immunization significantly increased FSH-beta mRNA expression compared with control rats. In contrast with the pituitary concentration of FSH, the effect of inhibin immunization on FSH-beta mRNA expression was not different between the stages. The present data demonstrate the involvement of inhibin in the decline of the secondary surge of FSH, and suggest that a factor or factors other than inhibin may also be responsible for the fall in FSH. Changes in the pituitary concentration of FSH and FSH-beta mRNA expression suggest that post-transcriptional mechanisms may be involved in the suppression of FSH secretion during oestrus.

Estrogen replacement therapy in postmenopausal women: a study of the efficacy of estriol and changes in plasma gonadotropin levels

The purpose of this study was to clarify the efficacy of estriol for estrogen replacement therapy in postmenopausal women with undefined symptoms and to evaluate endocrinological changes during therapyin relation to clinical outcome. Administration of 2 mg estriol in 168 postmenopausal patients was markedly effective in 22.6% of cases ,effective in 45.2% ,fairly effective in 14.3% ,and ineffective in17.9% of cases. The plasma concentration of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) after administration of estriol decreased significantly (p < 0.001) ,by 52.2% and 32.9%,respectively for markedly effective cases ,and by 39.1% and 48.0% for effective cases. In contrast ,the plasma estradiol concentration remained unchanged. On the other hand ,decreases in FSH and LH concentrationwere 13.9% and 5.9% for the fairly effective and 8.2% and 1.9% for ineffective cases ,demonstrating a significantly lower decrease in plasma FSH and LH levels than in the markedly effective and effectivecases (p < 0.001). For cases showing side-effects ,the plasma FSH and LH levels decreased by 52.0% and 64.3% ,respectively ,whereas the plasma estradiol level remained unchanged.In conclusion,the efficacy of estriol was significantly correlated to the degree of decrease in plasma FSH and LH levels in patients with undefined symptoms. In addition ,efficacy appeared to be correlated to the incidenceof side-effects. The degree of reduction of FSH (39.1-52.2%) and LH (48.0-64.3%) from the baseline may possibly be used as a guide to the therapeutic hormone levels during HRT. The presentresults suggest that plasma gonadotropin levels could be a useful indicator in the management of patients undergoing estrogen replacement therapy.

Increased plasma follicle-stimulating hormone concentrations in prepubertal gilts from lines selected for increased number of corpora lutea.

Plasma follicle-stimulating hormone (FSH) was evaluated in gilts from two studies in which ovulation rate was increased through direct selection for number of corpora lutea (CL) to determine whether selection for ovulation rate affected FSH secretion during prepubertal development. In the first study, 76 control and 110 selected gilts of University of Nebraska gene pool lines were bled twice during prepubertal development. Plasma FSH concentrations were greater (P < 0.05) at 53 (13.5%) and 75 (21.3%) d of age in selected than in control gilts. In the second study, 254 control gilts, 261 gilts from a line selected for ovulation rate, and 256 gilts from a line selected for uterine capacity were bled at three prepubertal ages. Plasma FSH was greater (P < 0.05), relative to controls, on d 34 (> 24%), 55 (> 13%), and 85 (> 10%) in White Composite gilts selected for either increased ovulation rate or for greater uterine capacity. Unilateral ovariectomy and hysterectomy were performed at 160 d of age on random gilts in these three lines (n = 377); weights of these organs were evaluated to determine whether selection affected their development. Ovarian and uterine weights were less (P < 0.01) in the control than in the ovulation rate line. Subsequently, ovulation rate was determined during pregnancy (n > or = 130 gilts/line). Controls had fewer (P < 0.01) CL (14.6) than gilts of the ovulation rate line (17.7) but numbers similar (P > 0.10) to those of gilts of the uterine capacity line (14.7). Within each line, plasma FSH only on d 85 correlated positively with subsequent ovulation rate (P < 0.03, 0.001, and 0.08; r = 0.17, 0.30, and 0.15 for control, ovulation rate, and uterine capacity lines, respectively). Ovarian weight at 160 d of age also correlated with subsequent ovulation rate (P < 0.03 and 0.001; r = 0.23 and 0.38) in control and ovulation rate gilts but not in uterine capacity gilts (P > 0.10; r = 0.11). Gilts selected for increased number of CL, in two independent studies, had greater concentrations of FSH during prepubertal development than respective controls. The modest but significant, positive association of FSH at 85 d of age with subsequent ovulation rate provides additional support for using plasma FSH in prepubertal gilts to indirectly select for ovulation rate.

Regulatory Role of Inhibin in Follicle-Stimulating Hormone Secretion and Folliculogenesis in the Guinea Pig.

The effects of unilateral and bilateral ovariectomy and passive immunization against inhibin on follicle-stimulating hormone (FSH) secretions and follicular development in the guinea pig were investigated. Bilateral ovariectomy decreased plasma immunoreactive (ir-) inhibin rapidly and increased plasma FSH significantly. Unilateral ovariectomy decreased plasma ir-inhibin and increased plasma FSH temporarily, and doubled the number of ova released from the remaining ovary at the subsequent ovulation in guinea pigs. Injection of 1.0 ml inhibin antiserum significantly increased concentrations of plasma FSH at 6 hr onwards and the number of small follicles (100-200 microm in diameter) at 48 hr after the injection in guinea pigs bearing progesterone-containing implants. In vitro bioassay showed that inhibin antiserum could neutralize the suppression of ovarian homogenate on FSH secretion from cultured rat anterior pituitary cells. These results confirm the evidence that the ovary is the main source of inhibin secretion and both in vitro bioassay and passive immunization against inhibin show that the inhibin is a major regulator in the follicular development through FSH secretion in guinea pigs.

Modulation of pituitary dopamine D1 or D2 receptors and secretion of follicle stimulating hormone and luteinizing hormone during the annual reproductive cycle of female rainbow trout.

The two gonadotrophins follicle stimulating hormone (FSH) and luteinizing hormone (LH) have distinct temporal expression and release profiles in fish, but little is known regarding their neuroendocrine control, especially for FSH. The present experiments were performed on previtellogenic, mature and preovulatory female trout. The catecholamine synthesis inhibitor, alpha-methyl-p-tyrosine, increased plasma LH and FSH concentrations of mature fish. The dopamine agonist apomorphine decreased and the dopamine antagonist domperidone increased plasma LH concentration of preovulatory fish and delayed ovulation, but did not modify plasma FSH concentration. The dopamine D2 agonist bromocryptine inhibited LH release in cultured gonadotrophs from mature and preovulatory fish, but not from previtellogenic fish. Bromocryptine also significantly inhibited basal and salmon gonadotrophin releasing-hormone (sGnRH)-induced FSH release from cultured gonadotrophs of mature fish, but not of preovulatory fish, and increased FSH release from gonadotrophs of previtellogenic fish. The dopamine D1 agonist SKF 38393 had no observed effect on the release of FSH and LH, at any reproductive stage studied. The D1 agonist SKF 38393, the D2 agonist bromocriptine and sGnRH had no observed effects on cell contents of FSH and LH. Taken together, these data suggest that, at the level of the pituitary, dopamine inhibits LH release as vitellogenesis proceeds, via activation of dopamine D2 receptors. We demonstrate for the first time in fish a control of FSH release (a dopamine control), especially in mature fish which have low circulating concentrations of FSH.

Follicle selection in cyclic guinea pigs with active immunization against inhibin α-subunit

Experiments were conducted to elucidate the mechanisms of active immunization against inhibin on ovarian follicular development and selection in guinea pigs. Estrous cycle was synchronized in experimental guinea pigs by implanting progesterone containing tubes. Antibodies that bound 125I-labeled bovine inhibin were produced by all guinea pigs receiving the inhibin vaccine (recombinant ovine α-subunit in oil emulsion) without any effects on duration of the estrous cycle. Active immunization against inhibin increased the plasma concentrations of progesterone during the luteal phase and the plasma concentrations of estradiol but failed to increase the plasma concentration of follicle-stimulating hormone (FSH) during preovulatory period. The treatment also increased the number of corpora lutea (from 1.3±0.3 to 7.0±1.6 per each ovary), and preovulatory sized follicles (from 1.8±0.6 to 7.0±1.6 per each ovary), and follicles stained positively for inhibin α-subunit (from 2.3±0.5 to 6.3±1.3 per each ovary) significantly. The results indicate that active immunization against inhibin enhances ovulation rate by affecting the follicle selection and only dominant follicle can be stained for inhibin α-subunit in guinea pigs. This study is firstly to provide direct evidence that inhibins play important role in follicle selections in guinea pigs.